These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25356996)

  • 21. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Opioid-Induced Constipation in Hospice Patients.
    Sera L; McPherson ML
    Am J Hosp Palliat Care; 2018 Feb; 35(2):330-335. PubMed ID: 28423917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When People with Opioid-Induced Constipation Speak: A Patient Survey.
    Epstein RS; Teagarden JR; Cimen A; Sostek M; Salimi T
    Adv Ther; 2017 Mar; 34(3):725-731. PubMed ID: 28181146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes.
    Siemens W; Becker G
    Ther Clin Risk Manag; 2016; 12():401-12. PubMed ID: 27042082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting outcome measures of functional constipation in children from 0 to 4 years of age.
    Kuizenga-Wessel S; Benninga MA; Tabbers MM
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):446-56. PubMed ID: 25406527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of opioid-induced constipation.
    Prichard D; Norton C; Bharucha AE
    Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in pharmacotherapy for opioid-induced constipation - a systematic review.
    Siemens W; Gaertner J; Becker G
    Expert Opin Pharmacother; 2015 Mar; 16(4):515-32. PubMed ID: 25539282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
    Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
    J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.
    Spierings EL; Brewer RP; Rauck RL; Losch-Beridon T; Mareya SM
    Pain Pract; 2017 Mar; 17(3):312-319. PubMed ID: 26990171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylnaltrexone bromide for the treatment of opioid-induced constipation.
    Mozaffari S; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2018 Jul; 19(10):1127-1135. PubMed ID: 29979903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Functional Characteristics of Nursing Facility Residents with Opioid-Induced Constipation.
    Allen C; Zarowitz BJ; O'Shea T; Datto C; Olufade T
    Consult Pharm; 2017 May; 32(5):285-298. PubMed ID: 28483009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the European Consensus on the treatment of opioid-induced constipation analgesic drugs.].
    Falbo PT; Cereda V; Manna G; Iannace A; Menghi A; Corona M; Lanzetta G
    Recenti Prog Med; 2019; 110(7):338-342. PubMed ID: 31379368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
    Ueberall MA; Müller-Lissner S; Buschmann-Kramm C; Bosse B
    J Int Med Res; 2011; 39(1):41-50. PubMed ID: 21672306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.
    Morlion B; Clemens KE; Dunlop W
    Clin Drug Investig; 2015 Jan; 35(1):1-11. PubMed ID: 25479959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
    Merchan C; Altshuler D; Papadopoulos J
    Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.
    Leonard J; Baker DE
    Ann Pharmacother; 2015 Mar; 49(3):360-5. PubMed ID: 25471070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
    Reimer K; Hopp M; Zenz M; Maier C; Holzer P; Mikus G; Bosse B; Smith K; Buschmann-Kramm C; Leyendecker P
    Pharmacology; 2009; 83(1):10-7. PubMed ID: 18957874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.
    Chokhavatia S; John ES; Bridgeman MB; Dixit D
    Drugs Aging; 2016 Aug; 33(8):557-74. PubMed ID: 27417446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
    Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
    J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.